Detailed price information for Telix Pharm Ltd (TLPPF) from The Globe and Mail including charting and trades.
Telix Pharmaceuticals maintains a Buy rating, driven by robust 3Q26 performance and the strategic ITM acquisition. Read more on TLX stock here.
Detailed price information for Telix Pharm Ltd (TLPPF) from The Globe and Mail including charting and trades.
Detailed price information for Telix Pharm Ltd (TLPPF) from The Globe and Mail including charting and trades.
The average of price targets set by Wall Street analysts indicates a potential upside of 83.4% in Telix Pharmaceuticals Limited (TLX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the United States (U.S.) Food and Drug Administration (FDA) has granted Fast Track designation for the Company's BiPASS® program.
Detailed price information for Telix Pharm Ltd (TLPPF) from The Globe and Mail including charting and trades.
Detailed price information for Telix Pharmaceuticals Limited ADR (TLX-Q) from The Globe and Mail including charting and trades.
Telix Pharmaceuticals Limited (NASDAQ:TLX) agreed on September 21 to acquire ITM Isotope Technologies Munich SE. The deal is worth up to $2.35 billion. Telix will pay $1.65 billion upfront, before cash and debt. A further $700 million follows if ITM’s lead drug wins approval and hits sales targets. Telix is paying mostly in its own […]
Telix Pharmaceuticals acquires ITM Isotope for $1.65B to create a radiopharmaceutical leader. Here is what investors need to know.
About This EventTelix Pharmaceuticals Limited (Nasdaq:TLX), a commercial-stage global radiopharmaceutical company, advancing precision diagnostics and targeted radionuclide therapies to improve outcomes for people with cancer, visits the Nasdaq MarketSite in Times Square.In honor of the occasion, Dr. Christian Behrenbruch, Managing Director & Group Chief Executive Officer rings the Closing Bell.
Telix Pharmaceuticals to buy Germany’s ITM Isotope in a $1.65B deal, boosting radiopharma scale and 2026 revenue outlook—read the details now.
Telix jumps on FDA approval of Pixclara for glioma FET-PET imaging. Read more here.
Detailed price information for Telix Pharm Ltd (TLPPF) from The Globe and Mail including charting and trades.
MELBOURNE, Australia and INDIANAPOLIS, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) advises that Dr. Christian Behrenbruch, Managing Director and Group CEO and Kevin Richardson, CEO, Precision Medicine will present at the upcoming Morgan Stanley 24th Annual Global Healthcare Conference and at the H.C. Wainwright 28th Annual Global Investment Conference, both in New York, NY. Presentation details: Morgan Stanley 24th Annual Global Healthcare Co
This is the newest page. Registered accounts read further back.